Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Neuromuscular blocking agents for tracheal intubation in pediatric patients: A systematic review and meta-analysis.

Vanlinthout LE, Geniets B, Driessen JJ, Saldien V, Lapré R, Berghmans J, Germaine U, Hens N.

Paediatr Anaesth. 2019 Dec 30. doi: 10.1111/pan.13806. [Epub ahead of print]

PMID:
31887248
2.

SimpactCyan 1.0: An Open-source Simulator for Individual-Based Models in HIV Epidemiology with R and Python Interfaces.

Liesenborgs J, Hendrickx DM, Kuylen E, Niyukuri D, Hens N, Delva W.

Sci Rep. 2019 Dec 17;9(1):19289. doi: 10.1038/s41598-019-55689-4.

3.

Ethnicity and response to primary three-dose hepatitis B vaccination in employees in the Netherlands, 1983 through 2017.

Koc ÖM, Menart C, Theodore J, Kremer C, Hens N, Koek GH, Oude Lashof AML.

J Med Virol. 2020 Mar;92(3):309-316. doi: 10.1002/jmv.25610. Epub 2019 Oct 29.

PMID:
31621084
4.

Inference of the generalized-growth model via maximum likelihood estimation: A reflection on the impact of overdispersion.

Ganyani T, Faes C, Hens N.

J Theor Biol. 2020 Jan 7;484:110029. doi: 10.1016/j.jtbi.2019.110029. Epub 2019 Sep 27.

PMID:
31568788
5.

Murine iPSC-derived microglia and macrophage cell culture models recapitulate distinct phenotypical and functional properties of classical and alternative neuro-immune polarisation.

Quarta A, Le Blon D, D'aes T, Pieters Z, Hamzei Taj S, Miró-Mur F, Luyckx E, Van Breedam E, Daans J, Goossens H, Dewilde S, Hens N, Pasque V, Planas AM, Hoehn M, Berneman Z, Ponsaerts P.

Brain Behav Immun. 2019 Nov;82:406-421. doi: 10.1016/j.bbi.2019.09.009. Epub 2019 Sep 13.

6.

Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration.

Willekens B, Presas-Rodríguez S, Mansilla MJ, Derdelinckx J, Lee WP, Nijs G, De Laere M, Wens I, Cras P, Parizel P, Van Hecke W, Ribbens A, Billiet T, Adams G, Couttenye MM, Navarro-Barriuso J, Teniente-Serra A, Quirant-Sánchez B, Lopez-Diaz de Cerio A, Inogés S, Prosper F, Kip A, Verheij H, Gross CC, Wiendl H, Van Ham MS, Ten Brinke A, Barriocanal AM, Massuet-Vilamajó A, Hens N, Berneman Z, Martínez-Cáceres E, Cools N, Ramo-Tello C; RESTORE consortium.

BMJ Open. 2019 Sep 9;9(9):e030309. doi: 10.1136/bmjopen-2019-030309.

7.

Quantity and quality of antibodies after acellular versus whole cell pertussis vaccines in infants born to mothers who received Tdap during pregnancy: a randomised trial.

Wanlapakorn N, Maertens K, Vongpunsawad S, Peunpa J, Tran TMP, Hens N, Van Damme P, Thiriard A, Raze D, Locht C, Poovorawan Y, Leuridan E.

Clin Infect Dis. 2019 Aug 16. pii: ciz778. doi: 10.1093/cid/ciz778. [Epub ahead of print]

PMID:
31418814
8.

Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.

Derdelinckx J, Mansilla MJ, De Laere M, Lee WP, Navarro-Barriuso J, Wens I, Nkansah I, Daans J, De Reu H, Jolanta Keliris A, Van Audekerke J, Vanreusel V, Pieters Z, Van der Linden A, Verhoye M, Molenberghs G, Hens N, Goossens H, Willekens B, Cras P, Ponsaerts P, Berneman ZN, Martínez-Cáceres EM, Cools N.

J Neuroinflammation. 2019 Aug 15;16(1):167. doi: 10.1186/s12974-019-1541-1.

9.

Time trend of prevalence and susceptibility to nitrofurantoin of urinary MDR Escherichia coli from outpatients.

Bruyndonckx R, Latour K, Atud GA, Dubovy P, Jaspers S, Hens N, Catry B, Goossens H, Coenen S.

J Antimicrob Chemother. 2019 Nov 1;74(11):3264-3267. doi: 10.1093/jac/dkz323.

PMID:
31377782
10.
11.

A Systematic Review of Social Contact Surveys to Inform Transmission Models of Close-contact Infections.

Hoang T, Coletti P, Melegaro A, Wallinga J, Grijalva CG, Edmunds JW, Beutels P, Hens N.

Epidemiology. 2019 Sep;30(5):723-736. doi: 10.1097/EDE.0000000000001047.

12.

The impact of behavioral interventions on co-infection dynamics: An exploration of the effects of home isolation.

Hendrickx DM, Abrams S, Hens N.

J Theor Biol. 2019 Sep 7;476:5-18. doi: 10.1016/j.jtbi.2019.05.017. Epub 2019 May 27.

13.

First-void urine as a non-invasive liquid biopsy source to detect vaccine-induced human papillomavirus antibodies originating from cervicovaginal secretions.

Van Keer S, Willhauck-Fleckenstein M, Pattyn J, Butt J, Tjalma WAA, Van Ostade X, Hens N, Van Damme P, Waterboer T, Vorsters A.

J Clin Virol. 2019 Aug;117:11-18. doi: 10.1016/j.jcv.2019.05.004. Epub 2019 May 11.

14.

Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam.

Pham TV, Nguyen HV, Aguirre AR, Nguyen VV, A Cleves M, Nguyen XX, Nguyen TT, Tran DT, Le HX, Hens N, Rosanas-Urgell A, D'Alessandro U, Speybroeck N, Erhart A.

PLoS Med. 2019 May 17;16(5):e1002784. doi: 10.1371/journal.pmed.1002784. eCollection 2019 May.

15.

The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: a comparative analysis with hepatitis A virus seroprevalence.

Smit GSA, Abrams S, Dorny P, Speybroeck N, Devleesschauwer B, Hutse V, Jansens H, Theeten H, Beutels P, Hens N.

Epidemiol Infect. 2019 Jan;147:e154. doi: 10.1017/S0950268819000487.

16.

Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium: A protocol for screening.

Koc ÖM, Hens N, Bielen R, Van Damme P, Robaeys G.

Medicine (Baltimore). 2019 May;98(18):e15412. doi: 10.1097/MD.0000000000015412.

17.

Households or Hotspots? Defining Intervention Targets for Malaria Elimination in Ratanakiri Province, Eastern Cambodia.

Bannister-Tyrrell M, Krit M, Sluydts V, Tho S, Sokny M, Mean V, Kim S, Menard D, Grietens KP, Abrams S, Hens N, Coosemans M, Bassat Q, van Hensbroek MB, Durnez L, Van Bortel W.

J Infect Dis. 2019 Aug 9;220(6):1034-1043. doi: 10.1093/infdis/jiz211.

18.

An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with Varilrix.

Keersmaekers N, Ogunjimi B, Van Damme P, Beutels P, Hens N.

Vaccine. 2019 May 1;37(19):2537-2553. doi: 10.1016/j.vaccine.2019.03.075. Epub 2019 Apr 8.

PMID:
30975567
19.

Household members do not contact each other at random: implications for infectious disease modelling.

Goeyvaerts N, Santermans E, Potter G, Torneri A, Van Kerckhove K, Willem L, Aerts M, Beutels P, Hens N.

Proc Biol Sci. 2018 Dec 19;285(1893):20182201. doi: 10.1098/rspb.2018.2201.

20.

Prevalence and risk factors of hepatitis B virus infection in Middle-Limburg Belgium, year 2017: Importance of migration.

Koc ÖM, Kremer C, Bielen R, Buscchots D, Hens N, Nevens F, Robaeys G.

J Med Virol. 2019 Aug;91(8):1479-1488. doi: 10.1002/jmv.25457. Epub 2019 Mar 25.

PMID:
30870580
21.

Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling.

Blaizot S, Herzog SA, Abrams S, Theeten H, Litzroth A, Hens N.

BMC Med Res Methodol. 2019 Mar 7;19(1):51. doi: 10.1186/s12874-019-0692-1.

22.

Screening for hepatitis C at the emergency department: Should babyboomers also be screened in Belgium?

Bielen R, Kremer C, Koc ÖM, Busschots D, Hendrickx DM, Vanelderen P, Hens N, Nevens F, Robaeys G.

Liver Int. 2019 Apr;39(4):667-675. doi: 10.1111/liv.14016. Epub 2018 Dec 20.

PMID:
30525269
23.

Mapping maternal mortality rate via spatial zero-inflated models for count data: A case study of facility-based maternal deaths from Mozambique.

Loquiha O, Hens N, Chavane L, Temmerman M, Osman N, Faes C, Aerts M.

PLoS One. 2018 Nov 9;13(11):e0202186. doi: 10.1371/journal.pone.0202186. eCollection 2018.

24.

The influence of ethnicity on disease outcome in patients with chronic hepatitis B infection.

Koc ÖM, Robaeys G, Yildirim B, Posthouwer D, Hens N, Koek GH.

J Med Virol. 2019 Apr;91(4):623-629. doi: 10.1002/jmv.25353. Epub 2018 Nov 28.

25.

Correlated gamma frailty models for bivariate survival time data.

Martins A, Aerts M, Hens N, Wienke A, Abrams S.

Stat Methods Med Res. 2019 Oct-Nov;28(10-11):3437-3450. doi: 10.1177/0962280218803127. Epub 2018 Oct 15.

PMID:
30319043
26.

Assessing the relationship between epidemic growth scaling and epidemic size: The 2014-16 Ebola epidemic in West Africa.

Ganyani T, Roosa K, Faes C, Hens N, Chowell G.

Epidemiol Infect. 2018 Oct 15:1-6. doi: 10.1017/S0950268818002819. [Epub ahead of print]

27.

Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders.

Bartholomeus E, De Neuter N, Meysman P, Suls A, Keersmaekers N, Elias G, Jansens H, Hens N, Smits E, Van Tendeloo V, Beutels P, Van Damme P, Ogunjimi B, Laukens K, Mortier G.

Vaccine. 2018 Oct 8;36(42):6282-6289. doi: 10.1016/j.vaccine.2018.09.001. Epub 2018 Sep 8.

PMID:
30205979
28.

Measures for concordance and discordance with applications in disease control and prevention.

Aerts M, Juga AJ, Hens N.

Stat Methods Med Res. 2019 Oct-Nov;28(10-11):3086-3099. doi: 10.1177/0962280218796252. Epub 2018 Sep 3.

PMID:
30175683
29.

Assessing inference of the basic reproduction number in an SIR model incorporating a growth-scaling parameter.

Ganyani T, Faes C, Chowell G, Hens N.

Stat Med. 2018 Dec 20;37(29):4490-4506. doi: 10.1002/sim.7935. Epub 2018 Aug 16.

PMID:
30117184
30.

Author Correction: Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox.

Ogunjimi B, Van den Bergh J, Meysman P, Heynderickx S, Bergs K, Jansens H, Leuridan E, Vorsters A, Goossens H, Laukens K, Cools N, Van Tendeloo V, Hens N, Van Damme P, Smits E, Beutels P.

Sci Rep. 2018 Jul 12;8(1):10824. doi: 10.1038/s41598-018-28930-9.

31.

Resurgence risk for measles, mumps and rubella in France in 2018 and 2020.

Béraud G, Abrams S, Beutels P, Dervaux B, Hens N.

Euro Surveill. 2018 Jun;23(25). doi: 10.2807/1560-7917.ES.2018.23.25.1700796.

32.

Memory CD4+ T cell receptor repertoire data mining as a tool for identifying cytomegalovirus serostatus.

De Neuter N, Bartholomeus E, Elias G, Keersmaekers N, Suls A, Jansens H, Smits E, Hens N, Beutels P, Van Damme P, Mortier G, Van Tendeloo V, Laukens K, Meysman P, Ogunjimi B.

Genes Immun. 2019 Mar;20(3):255-260. doi: 10.1038/s41435-018-0035-y. Epub 2018 Jun 15.

PMID:
29904098
33.

The role of age-mixing patterns in HIV transmission dynamics: Novel hypotheses from a field study in Cape Town, South Africa.

Beauclair R, Hens N, Delva W.

Epidemics. 2018 Dec;25:61-71. doi: 10.1016/j.epidem.2018.05.006. Epub 2018 May 18.

34.

Development of a prediction tool for patients presenting with acute cough in primary care: a prognostic study spanning six European countries.

Bruyndonckx R, Hens N, Verheij TJ, Aerts M, Ieven M, Butler CC, Little P, Goossens H, Coenen S; GRACE project group.

Br J Gen Pract. 2018 May;68(670):e342-e350. doi: 10.3399/bjgp18X695789. Epub 2018 Apr 9.

35.

Heterogeneous computing for epidemiological model fitting and simulation.

Kovac T, Haber T, Reeth FV, Hens N.

BMC Bioinformatics. 2018 Mar 16;19(1):101. doi: 10.1186/s12859-018-2108-3.

36.

Modelling time varying heterogeneity in recurrent infection processes: an application to serological data.

Abrams S, Wienke A, Hens N.

J R Stat Soc Ser C Appl Stat. 2018 Apr;67(3):687-704. doi: 10.1111/rssc.12236. Epub 2017 Aug 8.

37.
38.

Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women.

Wanlapakorn N, Maertens K, Chaithongwongwatthana S, Srimuan D, Suratannon N, Vongpunsawad S, Tran TMP, Hens N, Van Damme P, Locht C, Poovorawan Y, Leuridan E.

Vaccine. 2018 Mar 7;36(11):1453-1459. doi: 10.1016/j.vaccine.2018.01.059.

PMID:
29426663
39.

Current levels of gonorrhoea screening in MSM in Belgium may have little effect on prevalence: a modelling study.

Buyze J, Vanden Berghe W, Hens N, Kenyon C.

Epidemiol Infect. 2018 Feb;146(3):333-338. doi: 10.1017/S0950268818000092. Epub 2018 Feb 1.

PMID:
29386078
40.

The impact of regular school closure on seasonal influenza epidemics: a data-driven spatial transmission model for Belgium.

Luca G, Kerckhove KV, Coletti P, Poletto C, Bossuyt N, Hens N, Colizza V.

BMC Infect Dis. 2018 Jan 10;18(1):29. doi: 10.1186/s12879-017-2934-3.

41.

Predicting the cure rate of breast cancer using a new regression model with four regression structures.

Ramires TG, Cordeiro GM, Kattan MW, Hens N, Ortega EM.

Stat Methods Med Res. 2018 Nov;27(11):3207-3223. doi: 10.1177/0962280217695344. Epub 2017 Feb 23.

PMID:
29298615
42.

The shape of the contact-density function matters when modelling parasite transmission in fluctuating populations.

Borremans B, Reijniers J, Hens N, Leirs H.

R Soc Open Sci. 2017 Nov 22;4(11):171308. doi: 10.1098/rsos.171308. eCollection 2017 Nov.

43.

Mathematical models used to inform study design or surveillance systems in infectious diseases: a systematic review.

Herzog SA, Blaizot S, Hens N.

BMC Infect Dis. 2017 Dec 18;17(1):775. doi: 10.1186/s12879-017-2874-y.

44.

Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients.

Marcq E, Waele J, Audenaerde JV, Lion E, Santermans E, Hens N, Pauwels P, van Meerbeeck JP, Smits ELJ.

Oncotarget. 2017 Sep 21;8(52):89722-89735. doi: 10.18632/oncotarget.21113. eCollection 2017 Oct 27.

45.

Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis by bacterial and viral aetiology.

Bruyndonckx R, Stuart B, Little P, Hens N, Ieven M, Butler CC, Verheij T, Goossens H, Coenen S; GRACE project group.

Clin Microbiol Infect. 2018 Aug;24(8):871-876. doi: 10.1016/j.cmi.2017.10.032. Epub 2017 Nov 3.

46.

Using additive and coupled spatiotemporal SPDE models: a flexible illustration for predicting occurrence of Culicoides species.

Kifle YW, Hens N, Faes C.

Spat Spatiotemporal Epidemiol. 2017 Nov;23:11-34. doi: 10.1016/j.sste.2017.07.003. Epub 2017 Aug 14.

PMID:
29108688
47.

Simulation-based evaluation of the linear-mixed model in the presence of an increasing proportion of singletons.

Bruyndonckx R, Hens N, Aerts M.

Biom J. 2018 Jan;60(1):49-65. doi: 10.1002/bimj.201700025. Epub 2017 Oct 25.

PMID:
29067702
48.

Factors influencing risky sexual behaviour among Mozambican miners: a socio-epidemiological contribution for HIV prevention framework in Mozambique.

Martins-Fonteyn E, Loquiha O, Baltazar C, Thapa S, Boothe M, Raimundo I, Hens N, Aerts M, Meulemans H, Degomme O, Wouters E.

Int J Equity Health. 2017 Oct 10;16(1):179. doi: 10.1186/s12939-017-0674-z.

49.

Model-based inference for small area estimation with sampling weights.

Vandendijck Y, Faes C, Kirby RS, Lawson A, Hens N.

Spat Stat. 2016 Nov;18:455-473. doi: 10.1016/j.spasta.2016.09.004. Epub 2016 Oct 14.

50.

Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015).

Willem L, Verelst F, Bilcke J, Hens N, Beutels P.

BMC Infect Dis. 2017 Sep 11;17(1):612. doi: 10.1186/s12879-017-2699-8.

Supplemental Content

Support Center